Picture of Auxly Cannabis logo

XLY — Auxly Cannabis News Story

0.000.00%
ca flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSuper Stock

Canada's Auxly Cannabis Q2 revenue rises on higher volume sales

Canada's Auxly Cannabis Q2 revenue rises on higher volume sales


Overview

  • Canada cannabis products maker's Q2 net revenue rose 18% yr/yr

  • Adjusted EBITDA for Q2 increased 24% yr/yr, driven by improved gross profits

  • Company repurchased 2.6 mln shares and completed 14:1 share consolidation in July


Outlook

  • Auxly plans to invest C$10 mln to C$12 mln in capital projects in 2026

  • Company expects production capacity to rise 30% from 2025 levels by end of 2028

  • Auxly is actively evaluating export opportunities to support long-term international growth


Result Drivers

  • VOLUME AND PRICING - Revenue growth was primarily driven by higher incremental volumes across the core portfolio and improved pricing in the flower segment, partially offset by price compression in vape products

  • COST EFFICIENCY - Gross margin improvement resulted from manufacturing process enhancements, efficiency gains at the Charlottetown facility, and strategic procurement initiatives

  • OPERATING EXPENSES - Higher SG&A expenses reflected investments to support increased sales


Company press release: ID:nCNWV8t3qa


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q2 Revenue

Beat

C$45.80 mln

C$41.10 mln (1 Analyst)

Q2 Net Income

C$7.70 mln

Q2 Adjusted EBITDA

C$14.30 mln


Analyst Coverage

  • The one available analyst rating on the shares is "buy"

  • The average consensus recommendation for the pharmaceuticals peer group is "buy"

  • Wall Street's median 12-month price target for Auxly Cannabis Group Inc is C$3.50, about 8.4% above its August 12 closing price of C$3.23

  • The stock recently traded at 23 times the next 12-month earnings vs. a P/E of 15 three months ago


Reuters Recommended Reads

  • Aug 12 - Rubicon Organics Q2 revenue rises on yield gains at Pacifica facility

  • Aug 12 - MariMed Q2 revenue rises on wholesale, retail segment strength

  • Aug 12 - Cannabis grower Ascend Wellness' Q2 revenue rises after retail expansion


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Auxly Cannabis

See all news